LYMErix, the first vaccine against Lyme, was pulled from the market amid poor sales and pressure from the public. Now, over 20 years later, a new vaccine is in late-stage trials.
Guest: Cassandra Willyard
Host: Lizzie O'Leary
Need to set up your Slate Plus feed? If you subscribed through Slate.com, check out our FAQ at slate.com/podcastfaqs for easy instructions. Members subscribed via Apple Podcasts get automatic access—no setup required.
Hosted on Acast. See acast.com/privacy for more information.
Fler avsnitt av What Next: TBD | Tech, power, and the future
Visa alla avsnitt av What Next: TBD | Tech, power, and the futureWhat Next: TBD | Tech, power, and the future med Slate Podcasts finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
